New Targeted Therapy for Non-Small Cell Lung Cancer
Lung cancer ranks first in cancer mortality in Korea and cancer incidence in Korean men. More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant therapy. Cytotoxic agents, targeted therapy, and immune checkpoint inhibitors are used in chemotherapy according to the biop...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2023-01-01
|
| Series: | Tuberculosis and Respiratory Diseases |
| Subjects: | |
| Online Access: | http://e-trd.org/upload/pdf/trd-2022-0066.pdf |
| _version_ | 1797962707280855040 |
|---|---|
| author | Eun Ki Chung Seung Hyun Yong Eun Hye Lee Eun Young Kim Yoon Soo Chang Sang Hoon Lee |
| author_facet | Eun Ki Chung Seung Hyun Yong Eun Hye Lee Eun Young Kim Yoon Soo Chang Sang Hoon Lee |
| author_sort | Eun Ki Chung |
| collection | DOAJ |
| description | Lung cancer ranks first in cancer mortality in Korea and cancer incidence in Korean men. More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant therapy. Cytotoxic agents, targeted therapy, and immune checkpoint inhibitors are used in chemotherapy according to the biopsy and genetic test results. Among chemotherapy, the one that has developed rapidly is targeted therapy. The National Comprehensive Cancer Network (NCCN) guidelines have been updated recently for targeted therapy of multiple gene mutations, and targeted therapy is used not only for chemotherapy but also for adjuvant therapy. While previously targeted therapies have been developed for common genetic mutations, recently targeted therapies have been developed to overcome uncommon mutations or drug resistance that have occurred since previous targeted therapy. Therefore, this study describes recent, rapidly developing targeted therapies. |
| first_indexed | 2024-04-11T01:17:06Z |
| format | Article |
| id | doaj.art-31bda94a476c41b3ad82f53187f29baa |
| institution | Directory Open Access Journal |
| issn | 1738-3536 2005-6184 |
| language | English |
| last_indexed | 2024-04-11T01:17:06Z |
| publishDate | 2023-01-01 |
| publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
| record_format | Article |
| series | Tuberculosis and Respiratory Diseases |
| spelling | doaj.art-31bda94a476c41b3ad82f53187f29baa2023-01-03T23:11:59ZengThe Korean Academy of Tuberculosis and Respiratory DiseasesTuberculosis and Respiratory Diseases1738-35362005-61842023-01-0186111310.4046/trd.2022.00664798New Targeted Therapy for Non-Small Cell Lung CancerEun Ki Chung0Seung Hyun Yong1Eun Hye Lee2Eun Young Kim3Yoon Soo Chang4Sang Hoon Lee Division of Pulmonary, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea Division of Pulmonary, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea Division of Pulmonary, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea Division of Pulmonary, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea Division of Pulmonary, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaLung cancer ranks first in cancer mortality in Korea and cancer incidence in Korean men. More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant therapy. Cytotoxic agents, targeted therapy, and immune checkpoint inhibitors are used in chemotherapy according to the biopsy and genetic test results. Among chemotherapy, the one that has developed rapidly is targeted therapy. The National Comprehensive Cancer Network (NCCN) guidelines have been updated recently for targeted therapy of multiple gene mutations, and targeted therapy is used not only for chemotherapy but also for adjuvant therapy. While previously targeted therapies have been developed for common genetic mutations, recently targeted therapies have been developed to overcome uncommon mutations or drug resistance that have occurred since previous targeted therapy. Therefore, this study describes recent, rapidly developing targeted therapies.http://e-trd.org/upload/pdf/trd-2022-0066.pdfcarcinoma, non-small-cell lungmolecular targeted therapyprognosis |
| spellingShingle | Eun Ki Chung Seung Hyun Yong Eun Hye Lee Eun Young Kim Yoon Soo Chang Sang Hoon Lee New Targeted Therapy for Non-Small Cell Lung Cancer Tuberculosis and Respiratory Diseases carcinoma, non-small-cell lung molecular targeted therapy prognosis |
| title | New Targeted Therapy for Non-Small Cell Lung Cancer |
| title_full | New Targeted Therapy for Non-Small Cell Lung Cancer |
| title_fullStr | New Targeted Therapy for Non-Small Cell Lung Cancer |
| title_full_unstemmed | New Targeted Therapy for Non-Small Cell Lung Cancer |
| title_short | New Targeted Therapy for Non-Small Cell Lung Cancer |
| title_sort | new targeted therapy for non small cell lung cancer |
| topic | carcinoma, non-small-cell lung molecular targeted therapy prognosis |
| url | http://e-trd.org/upload/pdf/trd-2022-0066.pdf |
| work_keys_str_mv | AT eunkichung newtargetedtherapyfornonsmallcelllungcancer AT seunghyunyong newtargetedtherapyfornonsmallcelllungcancer AT eunhyelee newtargetedtherapyfornonsmallcelllungcancer AT eunyoungkim newtargetedtherapyfornonsmallcelllungcancer AT yoonsoochang newtargetedtherapyfornonsmallcelllungcancer AT sanghoonlee newtargetedtherapyfornonsmallcelllungcancer |